논문검색
Author Eun Kyung Park, Young Wook Kim, Joon Mo Lee, Sung Eun NamKoong, Do Gang Kim, Heung Jae Chun, Byoung Don Han, Su Mi Bae, Hyun Sun Jin, Jeong Im Sin, Woong Shick Ahn
Place of duty 1Catholic Research Institutes of Medical Science and 2Department of Obstetrics and Genecology, The Catholic University of Korea College of Medicine, Seoul, 3Department of Medicine, The Catholic University of Daegu, College of Medicine, Daegu, 4BMS Korea Research Center, Seoul, Korea.
Title Immunization with Adenoviral Vectors Carrying Recombinant IL-12 and E7 Enhanced the Antitumor Immunity against Human Papillomavirus 16-associated Tumor
Publicationinfo Cancer Res Treat. 2005 Feb; 037(01): 63-70.
Key_word Cervix Neoplasms,IL-12,HPV 16 E7
Full-Text
Abstract Purpose: Human papillomavirus (HPV) infection has a significant role in cervical carcinogenesis, and HPV oncoprotein E7 plays an important part in the formation and maintenance of cervical cancer. Interleukin-12 (IL-12) has been reported to induce a cellular immune response, and to suppress the tumor growth and the E7 production. Here we describe the use of adenoviral delivery of the HPV 16 E7 subunit (AdE7) along with adenoviral delivery of IL-12 (AdIL-12) in mice with HPV-associated tumors. Materials and Methods: Mice were injected with TC-1 cells to establish TC-1 tumor, and then they were immunized with AdIL-12 and/or AdE7 intratumorally. The anti tumor effects induced by AdIL-12 and/or E7 were evaluated by measuring the size of the tumor. E7-specific antibody and INF-gamma production in sera, and the T-helper cell proliferative responses were then measured. Cytotoxic T-lymphocyte (CTL) and T cell subset depletion studies were also performed. Results: Combined AdIL-12 and AdE7 infection at the tumor sites significantly enhanced the antitumor effects more than that of AdIL-12 or AdE7 single infection. This combined infection resulted in regression of the 9 mm sized tumors in 80% of animals as compare to the PBS group. E7-specific antibody and INF-gamma production in the sera, and the T-helper cell proliferative responses were significantly higher with coinfection of AdIL-12 and AdE7 than with AdIL-12 or AdE7 alone. CTL response induced by AdIL-12 and AdE7 in the coinjected group suggested that tumor suppression was mediated by mostly CD8 and only a little by the CD4 T cells. Conclusion: IL-12 and E7 application using adenovirus vector showed antitumor immunity effects against TC-1 tumor, and this system could be use in clinical applications for HPV-associated cancer. (ED note: nice abstract.) (Cancer Research and Treatment 2005;37:63-70)